Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?
about
Ectopic fat assessment focusing on cardiometabolic and renal riskIncreased fat in pancreas not associated with risk of pancreatitis post-endoscopic retrograde cholangiopancreatography.Links between ectopic fat and vascular disease in humansExpectations from imaging for pre-transplant evaluation of living donor liver transplantation.Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patientsDiagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis.Metabolic syndrome and hepatic resection: improving outcomeAccurate assessment of liver steatosis in animal models using a high throughput Raman fiber optic probe.Coffee consumption and NAFLD: a community based study on 1223 subjects.Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors.Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.Pediatric non-alcoholic fatty liver disease: an increasing public health issue.Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD.Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.Latest developments in the imaging of fibrotic liver disease.Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.Association of a lifestyle index with MRI-determined liver fat content in a general population study.Fibrosis imaging: Current concepts and future directions.
P2860
Q27015940-DBDEC2DF-E330-4812-8FDF-45110B609288Q33769357-05854023-145A-4956-9BFF-6EFB3714A813Q34076155-D91F46A7-FD53-44B5-96F2-5DB1F4DCA0DAQ34251813-E34DF0B1-320E-4A80-99AE-AA9D01510177Q34575945-76D6D520-C4A7-4631-85CB-DFDF194EA15CQ35038752-5192FF49-DC6A-4D88-89BD-937847B25E9DQ35249880-4013B649-994E-4F1A-A2EB-093D885248CFQ35629684-9871F70C-177F-4704-AF84-1EBEEFDB415CQ35756454-4339226F-8969-4FD0-806B-D82F6FF443D4Q35831047-26A3C06E-6BDD-475F-B815-6976B673039FQ36348762-592D58D7-72A8-47D1-B049-AA68DE7BD8F1Q36743255-7D38D79F-CFE7-4B5F-AE3E-53CDA2AEC217Q37206110-804DDAE1-77B2-4D52-94E5-669433D2702CQ37592952-37169D59-DD7D-430F-9348-F921A7E29D4EQ37601122-79462EC2-4E73-42F2-B92E-10872E92221BQ37976341-D8C8514D-B450-40F6-A44C-8A1A7CC42C38Q38162372-430CAB6F-432E-432A-B71F-14CBF97EBE54Q38246145-9FDBB38C-6F2D-46B6-8280-00BEF32DB553Q41231789-BF52525B-D3E5-4D76-AD24-6BCAA319A18AQ47376188-F9B0C286-08A1-4737-9397-816E5099C0AA
P2860
Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evaluation of diffuse liver st ...... aging: which modality is best?
@ast
Evaluation of diffuse liver st ...... aging: which modality is best?
@en
type
label
Evaluation of diffuse liver st ...... aging: which modality is best?
@ast
Evaluation of diffuse liver st ...... aging: which modality is best?
@en
prefLabel
Evaluation of diffuse liver st ...... aging: which modality is best?
@ast
Evaluation of diffuse liver st ...... aging: which modality is best?
@en
P2093
P2860
P1433
P1476
Evaluation of diffuse liver st ...... aging: which modality is best?
@en
P2093
Aliya Qayyum
Antonio C Westphalen
Benjamin M Yeh
Daryl M Chen
Fergus V Coakley
Kirk D Jones
Peter W Callen
Richard S Breiman
P2860
P304
P356
10.1016/J.CLINIMAG.2008.06.036
P577
2009-03-01T00:00:00Z